Non-steroidal anti-inflammatory drug

Results: 470



#Item
121HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZONTIVITY safely and effectively. See full prescribing information for ZONTIVITY. ™

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZONTIVITY safely and effectively. See full prescribing information for ZONTIVITY. ™

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-05-09 14:50:01
122Mistnet July-Sept 2014.pmd

Mistnet July-Sept 2014.pmd

Add to Reading List

Source URL: www.save-vultures.org

Language: English - Date: 2014-11-18 06:55:20
123Microsoft Word - Ch01_edt.doc

Microsoft Word - Ch01_edt.doc

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2013-08-23 13:13:26
124Rebatable OTC Drug List for Maine Medicaid OTC Drugs  Run Date: [removed]Note: Some OTC Diabetic Supplies, Nutritionals and Asthma Related DME are covered but not listed. Most over the counter products are subject to St

Rebatable OTC Drug List for Maine Medicaid OTC Drugs Run Date: [removed]Note: Some OTC Diabetic Supplies, Nutritionals and Asthma Related DME are covered but not listed. Most over the counter products are subject to St

Add to Reading List

Source URL: www.mainecarepdl.org

Language: English - Date: 2012-04-02 15:09:20
125Inlyta® (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg twice a day How supplied: 5mg and 1mg

Inlyta® (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg twice a day How supplied: 5mg and 1mg

Add to Reading List

Source URL: dev66.geckodesigns.com

Language: English - Date: 2014-10-30 16:15:33
126Actions Taken by FDA Center for Veterinary Medicine The following corrections or additions to the list were completed in October[removed]Original Approvals This section displays the original approval. To read the complete

Actions Taken by FDA Center for Veterinary Medicine The following corrections or additions to the list were completed in October[removed]Original Approvals This section displays the original approval. To read the complete

Add to Reading List

Source URL: www.fda.gov

Language: English
12711th September[removed]PAGB response to NSAID study In response to a new study published in Circulation, an American Heart Association journal, PAGB would like to highlight that the study only looked at prescribed medicati

11th September[removed]PAGB response to NSAID study In response to a new study published in Circulation, an American Heart Association journal, PAGB would like to highlight that the study only looked at prescribed medicati

Add to Reading List

Source URL: www.pagb.co.uk

Language: English - Date: 2012-09-11 13:22:51
128PART 3 EXCEPTION DRUG STATUS (EDS) Certain drugs are approved for coverage under the Exception Drug Status (EDS) Program when they meet specific criteria and upon review and recommendation of the Manitoba Drug Standards

PART 3 EXCEPTION DRUG STATUS (EDS) Certain drugs are approved for coverage under the Exception Drug Status (EDS) Program when they meet specific criteria and upon review and recommendation of the Manitoba Drug Standards

Add to Reading List

Source URL: www.gov.mb.ca

Language: English - Date: 2014-11-18 11:42:03
129Processing of Touhy Requests or Subpoenas

Processing of Touhy Requests or Subpoenas

Add to Reading List

Source URL: www.blm.gov

Language: English - Date: 2015-01-04 01:30:09
130Microsoft Word - MoH clean CMI pfcnmetht10310.doc

Microsoft Word - MoH clean CMI pfcnmetht10310.doc

Add to Reading List

Source URL: www.medsafe.govt.nz

Language: English - Date: 2014-12-30 22:57:59